EVALUATION OF LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB THERAPY IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME: RESULTS FROM BETA-CONFIDENT REGISTRY

被引：0
|
作者：
Kuemmerle-Deschner, J. [1 ]
Hoffman, H. [2 ]
Hawkins, P. [3 ]
van der Poll, T. [4 ]
Walker, U. [5 ]
Speziale, A. [6 ]
Tilson, H. [7 ]
机构：
[1] Univ Hosp Tuebingen, Tubingen, Germany
[2] Univ Calif San Diego, La Jolla, CA 92093 USA
[3] UCL, Sch Med, London, England
[4] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands
[5] Univ Hosp, Basel, Switzerland
[6] Novartis Pharma AG, Basel, Switzerland
[7] Univ N Carolina, Chapel Hill, NC USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.2224
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0524
引用
收藏
页码：850 / 850
页数：1
相关论文
共 50 条
  • [41] Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndrome
    Elmi, Abdulkadir A.
    Wynne, Karen
    Cheng, Iek L.
    Eleftheriou, Despina
    Lachmann, Helen J.
    Hawkins, Philip N.
    Brogan, Paul
    PEDIATRIC RHEUMATOLOGY, 2019, 17 (1)
  • [42] Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndrome
    Abdulkadir A. Elmi
    Karen Wynne
    Iek L. Cheng
    Despina Eleftheriou
    Helen J. Lachmann
    Philip N. Hawkins
    Paul Brogan
    Pediatric Rheumatology, 17
  • [43] Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry
    Oommen, Prasad T.
    Kallinich, Tilmann
    Rech, Juergen
    Blank, Norbert
    Weber-Arden, Julia
    Kuemmerle-Deschner, Jasmin B.
    RHEUMATOLOGY AND THERAPY, 2025, 12 (01) : 137 - 155
  • [44] Long-Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: Results From a Phase III Trial
    Gattorno, Marco
    Obici, Laura
    Penades, Inmaculada Calvo
    Kallinich, Tilmann
    Benseler, Susanne
    Dekker, Elise
    Levy, Jeremy
    De Benedetti, Fabrizio
    Lachmann, Helen
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (02) : 304 - 312
  • [45] Long-term Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - Interim Analysis of the RELIANCE Registry
    Kuemmerle-Deschner, Jasmin
    Henes, Jorg
    Kortus-Goetze, Birgit
    Kallinich, Tilmann
    Oommen, Prasad T.
    Rech, Juergen
    Weller-Heinemann, Frank
    Horneff, Gerd
    Foeldvari, Ivan
    Janda, Ales
    Schuetz, Catharina
    Dressler, Frank
    Borte, Michael
    Hufnagel, Markus
    Braner, Axel
    Meier, Florian
    Fiene, Michael
    Weber-Arden, Julia
    Blank, Norbert
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 379 - 380
  • [46] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH TRAPS (TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Blank, N.
    Schuetz, C.
    Hufnagel, M.
    Horneff, G.
    Borte, M.
    Kallinich, T.
    Oommen, P.
    Janda, A.
    Henes, J.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1162 - 1163
  • [47] EFFECT OF LONG-TERM TREATMENT WITH ANAKINRA (KINERET®) ON BONE MINERAL DENSITY IN PATIENTS WITH SEVERE CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES
    Timdahl, K.
    Goldbach-Mansky, R.
    Leinonen, M.
    Olivecrona, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 386 - 386
  • [48] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH TRAPS (TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Blank, N.
    Henes, J.
    Kallinich, T.
    Oommen, P.
    Schuetz, C.
    Borte, M.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 972 - 973
  • [49] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH TRAPS (TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Blank, N.
    Schuetz, C.
    Henes, J.
    Kallinich, T.
    Oommen, P.
    Borte, M.
    Hufnagel, M.
    Janda, A.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 347 - 347
  • [50] Canakinumab in Patients with Tumor Necrosis Factor Receptor-associated Periodic Syndrome (TRAPS) - Long-term Efficacy and Safety Data from a RELIANCE Registry Interim Analysis
    Blank, Norbert
    Schuetz, Catharina
    Henes, Joerg
    Kallinich, Tilmann
    Oommen, Prasad T.
    Borte, Michael
    Hufnagel, Markus
    Janda, Ales
    Weber-Arden, Julia
    Kuemmerle-Deschner, Jasmin B.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1614 - 1616
12345